Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Argus Health
US Army
US Department of Justice
Deloitte
Chubb
AstraZeneca
Baxter
Teva
Fuji

Generated: January 19, 2018

DrugPatentWatch Database Preview

Vernalis R And D Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for VERNALIS R AND D LTD, and when can generic versions of VERNALIS R AND D LTD drugs launch?

VERNALIS R AND D LTD has two approved drugs.

There are eight US patents protecting VERNALIS R AND D LTD drugs.

There are fifty-six patent family members on VERNALIS R AND D LTD drugs in fourteen countries.

Summary for Vernalis R And D Ltd
International Patents:56
US Patents:8
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Vernalis R And D Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Vernalis R And D Ltd TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Vernalis R And D Ltd TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Vernalis R And D Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,667,057 Levofloxacin antibiotic product, use and formulation thereof ➤ Subscribe
7,108,859 Antineoplastic product, use and formulation thereof ➤ Subscribe
6,541,014 Antiviral product, use and formulation thereof ➤ Subscribe
8,747,902 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
7,025,989 Multiple-delayed released antibiotic product, use and formulation thereof ➤ Subscribe
8,202,537 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
8,889,187 Once a day amoxicillin product comprising immediate and delayed release dosage forms ➤ Subscribe
8,337,890 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
8,303,988 Antifungal once-a-day product, use and formulation thereof ➤ Subscribe
7,157,095 Multiple-delayed release antifungal product, use and formulation thereof ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Vernalis R And D Ltd Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Daiichi Sankyo
Cipla
Johnson and Johnson
Accenture
Novartis
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot